Why hepatic vein systolic reversal matters
Hepatic vein systolic reversal is a strong supportive sign of severe TR. It means systolic backflow is no longer confined to the right atrium — it has propagated through the IVC into the hepatic venous system. This is not just a valve finding. It is a venous congestion signal.
An echo report may mention 'hepatic vein systolic flow reversal' in the tricuspid regurgitation section. That finding is easy to read as just another Doppler detail. Clinically, it means much more: systolic backflow from the right atrium is reaching the abdominal venous system.
Key takeaway
Hepatic vein systolic reversal strongly supports severe TR. It also tells you that the hemodynamic effect of TR extends beyond the right atrium into the systemic venous circulation.
Key points
- Normal hepatic venous flow is predominantly forward toward the heart, with systolic and diastolic forward components.
- In severe TR, systolic backflow from the RA can propagate through the IVC and reverse systolic flow in the hepatic veins.
- Hepatic vein systolic reversal is a major supportive sign of severe TR.
- It should be interpreted as a venous congestion signal, not just an isolated echo waveform.
- Rhythm, RA pressure, respiration, sampling position, and image quality can affect the waveform.
- Atrial fibrillation can alter hepatic vein flow independently of TR severity.
- Reversal alone does not determine intervention. Mechanism, symptoms, RV function, venous congestion, pulmonary pressure, and procedural risk still matter.
When to read this
Read this when an echo report notes hepatic vein systolic reversal and you want to understand how much weight to give it. It is especially important when TR is accompanied by IVC plethora, edema, ascites, renal dysfunction, or abnormal liver tests.
Normal hepatic vein flow
Normally, hepatic venous flow is directed toward the heart. The typical pattern includes systolic forward flow — the S wave — and diastolic forward flow — the D wave. Brief reversal components may appear during the cardiac cycle, but the dominant direction remains toward the right atrium.
What severe TR does
In severe TR, a large volume of blood regurgitates into the RA during RV systole. As RA pressure rises, systolic backpressure can be transmitted into the IVC and hepatic veins.
Instead of moving toward the heart during systole, hepatic venous flow is pushed backward. That is hepatic vein systolic reversal.
Why this matters perioperatively
Hepatic vein systolic reversal is more than a severity marker. It tells you that venous pressure is being transmitted into the systemic venous circulation. In the perioperative setting, that can matter in several ways:
- Hepatic congestion: chronic congestion may contribute to abnormal liver tests, impaired synthetic function, or altered drug handling.
- Renal venous congestion: when combined with low cardiac output or hemodynamic stress, it may increase the risk of AKI and cardiorenal syndrome.
- IVC plethora and poor preload responsiveness: fluid loading may fail to improve cardiac output and may worsen congestion.
- Ascites and peripheral edema: signs of advanced systemic venous congestion in chronic severe TR.
Induction, positive-pressure ventilation, bleeding, hypoxia, acidosis, and increased pulmonary vascular resistance can all worsen right-heart performance in this setting.
Important caveat: atrial fibrillation
Atrial fibrillation can change hepatic vein flow patterns independently of TR severity. Loss of atrial contraction, elevated RA pressure, respiratory variation, and technical factors can all complicate interpretation. In AF, hepatic vein systolic reversal should be read alongside other severity signals: vena contracta width, PISA-derived EROA, regurgitant volume, CW Doppler contour, RA/RV enlargement, and IVC findings.
How it fits into the TR Severity Tool
The TR Severity Tool treats hepatic vein systolic reversal as an important severe-range signal. By itself, it strongly supports severe TR; when it appears with other severe-range findings, confidence in a severe TR pattern increases.
The tool does not decide intervention. The next question is mechanism, symptoms, RV function, venous congestion, pulmonary pressure, and the broader clinical context assessed by the TR Intervention Navigator.
- Otto CM, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol. 2021;77(4):e25–e197.
- Zoghbi WA, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation. J Am Soc Echocardiogr. 2017.
Apply this in practice
Grade TR severity using ACC/AHA VHD 2020 integrated criteria.
Open TR Severity Tool